accountJust weeks after completing its $3.6 billion purchase of King Pharmaceuticals, Pfizer Inc (PFE.N) has recalled an opioid painkiller obtained in the deal and said it could remain unavailable for... NEW YORK, March 16 Embeda, which has annual sales...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer recalls pain drug acquired in King deal
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account